BACKGROUND: Antibiotic resistance is a growing concern and antibiotic usage the main contributing factor, but there are few studies examining antibiotic use and resistance in children. AIM: To investigate the association between previous trimethoprim prescribing and resistance in urinary Escherichia coli (E. coli) isolates in children. DESIGN AND SETTING: Retrospective, population cohort study in Tayside, Scotland. METHOD: Multilevel modelling of linked microbiology and dispensed prescribing data for 1373 ≤16-year-olds with E. coli urinary isolates in 2004-2009, examining the association between prior trimethoprim prescription and subsequent trimethoprim resistance in people with urinary E. coli isolates. RESULTS: Trimethoprim resistance was common (26.6%, 95% confidence interval [CI] = 24.6 to 28.6). Previous trimethoprim prescription was associated with subsequent culture of trimethoprim-resistant E. coli, with more recent prescription being more strongly associated with resistance. After adjusting for the number of previous E. coli isolates and sample year, trimethoprim prescribing in the previous 84 days remained significantly associated with culturing trimethoprim-resistant E. coli (adjusted OR 4.71, 95% CI = 1.83 to 12.16 for the previous 15-28 days versus never prescribed; adjusted OR 3.16, 95% CI = 1.63 to 6.13 for the previous 29-84 days); however, associations were not statistically significant for longer periods since prior exposure. CONCLUSION: Trimethoprim prescription has implications for future resistance in individual children, as well as at population level. Clinicians must ensure appropriateness of treatment choice and duration, and alternative antibiotics should be considered for childhood urinary tract infections if trimethoprim has been prescribed in the preceding 3 months.
BACKGROUND: Antibiotic resistance is a growing concern and antibiotic usage the main contributing factor, but there are few studies examining antibiotic use and resistance in children. AIM: To investigate the association between previous trimethoprim prescribing and resistance in urinary Escherichia coli (E. coli) isolates in children. DESIGN AND SETTING: Retrospective, population cohort study in Tayside, Scotland. METHOD: Multilevel modelling of linked microbiology and dispensed prescribing data for 1373 ≤16-year-olds with E. coli urinary isolates in 2004-2009, examining the association between prior trimethoprim prescription and subsequent trimethoprim resistance in people with urinary E. coli isolates. RESULTS:Trimethoprim resistance was common (26.6%, 95% confidence interval [CI] = 24.6 to 28.6). Previous trimethoprim prescription was associated with subsequent culture of trimethoprim-resistant E. coli, with more recent prescription being more strongly associated with resistance. After adjusting for the number of previous E. coli isolates and sample year, trimethoprim prescribing in the previous 84 days remained significantly associated with culturing trimethoprim-resistant E. coli (adjusted OR 4.71, 95% CI = 1.83 to 12.16 for the previous 15-28 days versus never prescribed; adjusted OR 3.16, 95% CI = 1.63 to 6.13 for the previous 29-84 days); however, associations were not statistically significant for longer periods since prior exposure. CONCLUSION:Trimethoprim prescription has implications for future resistance in individual children, as well as at population level. Clinicians must ensure appropriateness of treatment choice and duration, and alternative antibiotics should be considered for childhood urinary tract infections if trimethoprim has been prescribed in the preceding 3 months.
Authors: H Seppälä; T Klaukka; J Vuopio-Varkila; A Muotiala; H Helenius; K Lager; P Huovinen Journal: N Engl J Med Date: 1997-08-14 Impact factor: 91.245
Authors: Christopher C Butler; Sharon Hillier; Zoë Roberts; Frank Dunstan; Anthony Howard; Stephen Palmer Journal: Br J Gen Pract Date: 2006-09 Impact factor: 5.386
Authors: M Fasihul Alam; David Cohen; Christopher Butler; Frank Dunstan; Zoe Roberts; Sharon Hillier; Stephen Palmer Journal: Int J Antimicrob Agents Date: 2008-12-16 Impact factor: 5.283
Authors: Kathryn O'Brien; Thomas Wyn Bellis; Mark Kelson; Kerenza Hood; Christopher C Butler; Adrian Edwards Journal: Br J Gen Pract Date: 2015-09 Impact factor: 5.386
Authors: Virginia Hernandez-Santiago; Peter G Davey; Dilip Nathwani; Charis A Marwick; Bruce Guthrie Journal: PLoS Med Date: 2019-06-07 Impact factor: 11.069
Authors: Michael Cammarata; Ross Thyer; Michael Lombardo; Amy Anderson; Dennis Wright; Andrew Ellington; Jennifer S Brodbelt Journal: Chem Sci Date: 2017-03-28 Impact factor: 9.825